Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% | -.--% | -.--% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2019 | Gewicht | 2020 | Gewicht | Delta |
---|---|---|---|---|---|
Oral and Topical Cannabis and Non-cannabis Based Pharmaceuticals
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +377,77% |
Verkoop per regio
USD in miljoen | 2019 | Gewicht | 2020 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +377,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arthur Hall
CEO | Chief Executive Officer | - | - |
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
Chief Operating Officer | - | 08-03-19 | |
Gary C. Bernard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
Arthur Hall
CEO | Chief Executive Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 059 725 348 | 1 059 725 348 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Rising Biosciences, Inc.
1190 Cleveland Road
44870, Sandusky
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 1,06K | |
+11,67% | 8 mld. | |
-6,98% | 6,06 mld. | |
+8,18% | 5,78 mld. | |
+1,55% | 4,42 mld. | |
+9,47% | 4,22 mld. | |
+14,85% | 3,77 mld. | |
-2,78% | 3,07 mld. | |
+15,03% | 2,95 mld. | |
+44,80% | 2,2 mld. |
- Beurs
- Aandelen
- Koers RBII
- Onderneming Rising BioSciences, Inc.